Ibere
IBERIbere Pharmaceuticals Price (IBER)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
No Data
Revenue and Profitability
| Year | 2020 | 2021 |
|---|---|---|
| Revenue | - | 0 |
| Net Income | - | 1,561,747 |
| FCF USD | - | -868,746 |
| OCF USD | - | -868,746 |
Financial Health - DEBT
| Year | 2020 | 2021 |
|---|---|---|
| YTPD | - | 0.00 |
| D/E | 8.78 | 0.00 |
| CA/CL | 0.27 | 1.86 |
| TA/TL | 1.03 | 12.02 |
| Total Debt | 169,000 | 0 |
Management Performance
| Year | 2020 | 2021 |
|---|---|---|
| ROIC | - | -0.80% |
| ROE | - | 1.23% |
| ROA | - | 1.13% |
| NM % | - | - |
| FCF / R% | - | 0.00% |
| FCF / NI% | - | -55.63% |
| Operating Margin (OM) | - | - |
Per Share
| Year | 2020 | 2021 |
|---|---|---|
| EPS | 0.00 | 0.11 |
| SPS | 0.00 | 0.00 |
| OCPS | 0.00 | -0.06 |
| FCPS | 0.00 | -0.06 |
| BVPS | 0.00 | 8.55 |
Per Share - CAGR
| Year | 2020 | 2021 |
|---|---|---|
| CAGR-EPS | 0.00 | 0.11 |
| CAGR-SPS | 0.00 | 0.00 |
| CAGR-OCPS | 0.00 | -0.06 |
| CAGR-FCPS | 0.00 | -0.06 |
| CAGR-BVPS | 0.00 | 8.55 |